Ascend Wellness Holdings, Inc. (AAWH) stock
AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026Market cap $79.60MP/E –Yield –
Ascend Wellness ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Ascend Wellness's ebitda for the twelve months ending Jun 30, 2026 was $48.52M, down 17.8% year over year. For fiscal 2025 it was $56.52M, down 20.3% from the year before. The highest annual figure on record is $70.89M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.52M | -20.3% |
| FY2024 | Dec 31, 2024 | $70.89M | +28.0% |
| FY2023 | Dec 31, 2023 | $55.36M | +87.2% |
| FY2022 | Dec 31, 2022 | $29.58M | +489.8% |
| FY2021 | Dec 31, 2021 | $5.02M | -75.4% |
| FY2020 | Dec 31, 2020 | $20.41M | – |
| FY2019 | Dec 31, 2019 | -$22.02M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.81M | +91.8% |
| Q1 FY2026 | Mar 31, 2026 | $20.83M | -0.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.36M | -85.8% |
| Q3 FY2025 | Sep 30, 2025 | $8.52M | +34.2% |
| Q2 FY2025 | Jun 30, 2025 | $8.25M | +16.9% |
| Q1 FY2025 | Mar 31, 2025 | $20.89M | +10.2% |
| Q4 FY2024 | Dec 31, 2024 | $23.57M | +53.5% |
| Q3 FY2024 | Sep 30, 2024 | $6.35M | -42.5% |
| Q2 FY2024 | Jun 30, 2024 | $7.05M | – |
| Q1 FY2024 | Mar 31, 2024 | $18.96M | -14.6% |
| Q4 FY2023 | Dec 31, 2023 | $15.36M | -7.9% |
| Q3 FY2023 | Sep 30, 2023 | $11.04M | +92.1% |
| Q2 FY2023 | Jun 30, 2023 | -$945.00K | -138.5% |
| Q1 FY2023 | Mar 31, 2023 | $22.20M | – |
| Q4 FY2022 | Dec 31, 2022 | $16.66M | +247.5% |
| Q3 FY2022 | Sep 30, 2022 | $5.75M | -59.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.45M | -61.5% |
| Q1 FY2022 | Mar 31, 2022 | -$4.86M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.80M | -30.7% |
| Q3 FY2021 | Sep 30, 2021 | $14.13M | +150.1% |
| Q2 FY2021 | Jun 30, 2021 | $6.37M | +52.8% |
| Q1 FY2021 | Mar 31, 2021 | -$25.74M | -1812.3% |
| Q4 FY2020 | Dec 31, 2020 | $6.93M | – |
| Q3 FY2020 | Sep 30, 2020 | $5.65M | – |
| Q2 FY2020 | Jun 30, 2020 | $4.17M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.50M | – |
See a number that looks wrong?